The following is sponsored content from the Hoskinson Government and Policy Center.
The Hoskinson Government and Policy Center is proud to endorse the Stem Cell Freedom Act (Senate File 48), a landmark piece of legislation designed to advance medical freedom and spur healthcare innovation in Wyoming. The legislation expands access to stem cell therapies in Wyoming while also putting in place important restrictions on the type of treatments allowed, ensuring strong safety standards for patients. Critically, the legislation also explicitly prohibits the use of stem cells derived from abortion-related tissues.”
Building on the advances in medical freedom and patient choice secured by Wyoming’s 2015 Right to Try Act, this legislation establishes a clear, responsible framework allowing physicians to recommend and perform stem cell therapies that have not yet received full approval from the U.S. Food and Drug Administration (FDA).
Wyoming State Senator Eric Barlow of Gillette is the lead sponsor of the Stem Cell Freedom Act (Senate File 48), which is being considered in this year’s Wyoming Legislature. He’s joined by co-sponsor Reps. Jeremy Haroldson, R-Wheatland, Ken Clouston, R-Gillette, and Sens. Evie Brennan, R-Cheyenne, Lynn Hutchings, R-Cheyenne, in supporting the bill. The Hoskinson Health and Wellness Clinic, located in Barlow’s hometown of Gillette, is actively studying therapeutic uses of adult stem cells and is preparing to offer stem cell therapy with the passage of this bill.
“For too many patients, the federal system moves far slower than illness or injury,” Barlow said. “The legislation reflects Wyoming’s legacy of local control and Right To Try approach, which is designed to empower patients, protect physicians who act responsibly, and keep government out of the way. Just like the Right to Try Act, this legislation incorporates important safeguards, including informed consent and adherence to relevant scope of practice and medical standards of care a patient must sign off on in order to receive stem cell therapy.”
Under SF 48, patients may access therapies that use their own cells for life-improving treatments. These cells are often harvested from fat tissue and are done in accordance with good medical practice standards.
Passing SF 48 into law would mark a great victory for medical freedom and patient choice in Wyoming. If passed, doctors providing stem cell recommendations and treatment would no longer have to put their medical license at risk solely by recommending or providing non-FDA approved stem cell therapy. Weighing the potential benefits and risks of receiving stem cell therapy is a decision that should reside with the patient and their doctor, not the government.
U.S. Secretary of Health and Human Services Secretary Robert F. Kennedy Jr. has criticized the FDA’s suppression and over-regulation of stem cell therapy and other treatments. The Stem Cell Freedom Act provides Wyoming the opportunity to responsibly advance individual liberty, empower physician-patient decisions, and spur healthcare innovation within our own borders. Wyoming should lead the way on stem cell therapy and patient-centered medical policy.
The Hoskinson Health and Wellness Clinic is currently studying how stem cell therapy could be used to slow down the physical and molecular changes associated with aging.
The Hoskinson Government and Policy Center advances principled policy to enhance government transparency, innovation, and Wyoming's blockchain and emerging technology industries. The Policy Center was founded by Charles Hoskinson, co-founder of the Cardano and Ethereum blockchain platforms. Visit Hoskinsonpolicy.com and follow the Hoskinson Government and Policy Center on Facebook, X, and LinkedIn for the latest updates.
